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The stability of heterologous proteins secreted by gram-positive bacteria is greatly influenced by the micro-
environment on the trans side of the cytoplasmic membrane, and secreted heterologous proteins are susceptible
to rapid degradation by host cell proteases. In Bacillus subtilis, degradation occurs either as the proteins emerge
from the presecretory translocase and prior to folding into their native conformation or after the native
conformation has been reached. The former process generally involves membrane- and/or cell wall-bound
proteases, while the latter involves proteases that are released into the culture medium. The identification and
manipulation of factors that influence the folding of heterologous proteins has the potential to improve the
yield of secreted heterologous proteins. Recombinant anthrax protective antigen (rPA) has been used as a
model secreted heterologous protein because it is sensitive to proteolytic degradation both before and after
folding into its native conformation. This paper describes the influence of the microenvironment on the trans
side of the cytoplasmic membrane on the stability of rPA. Specifically, we have determined the influence of net
cell wall charge and its modulation by the extent to which the anionic polymer teichoic acid is D-alanylated on
the secretion and stability of rPA. The potential role of the dlt operon, responsible for D-alanylation, was
investigated using a Bacillus subtilis strain encoding an inducible dlt operon. We show that, in the absence of
D-alanylation, the yield of secreted rPA is increased 2.5-fold. The function of D-alanylation and the use of rPA
as a model protein are evaluated with respect to the optimization of B. subtilis for the secretion of heterologous
proteins.
Bacillus anthracis, a gram-positive spore-forming bacterium,
is the causative agent of anthrax. Expression of full virulence is
determined by the production of two major virulence factors,
the anthrax toxins and a poly-D-glutamic acid capsule, encoded
by plasmids pXO1 and pXO2, respectively (14, 29). The prod-
ucts of three genes combine to form the two bipartite toxins of
B. anthracis. Protective antigen (PA) and edema factor (EF)
combine to form edema toxin, while PA combines with lethal
factor (LF) to form lethal toxin.
It has long been known that an extracellular protective an-
tigen is produced when B. anthracis is grown in vivo (6). PA
alone is nontoxic and induces a protective immune response
(45). The currently licensed vaccines against anthrax in both
the United States and United Kingdom are based on precipi-
tated cell extracts of B. anthracis (United States,V770-NP1-R
absorbed onto aluminum hydroxide gel; United Kingdom,
Sterne 34F2 precipitated by alum) (15). Although the Sterne
United Kingdom vaccine strain is attenuated, it is still cat-
egorized as an Advisory Committee on Dangerous Pathogens
(ACDP) category III pathogen; therefore, vaccine production
requires the use of expensive high-level containment facilities.
Besides PA, these vaccines contain trace amounts of EF and
LF (the other potentially toxic components) and a variety of
medium-derived proteins, any of which may contribute to the
short-lived side effects recorded in some individuals following
vaccination (47).
To overcome these problems, attempts have been made to
produce recombinant protective antigen (rPA) in a variety of
heterologous hosts, including B. subtilis (20), Escherichia coli
(39), Salmonella enterica serovar Typhimurium (12), Lactoba-
cillus casei (54), and viral hosts, including baculovirus and
vaccinia virus (19). Of the hosts tested so far, only B. subtilis
has been found to give yields of rPA that are compatible with
large-scale production (3, 4, 5).
Bacillus species in general, and B. subtilis in particular, are
highly valued commercially for their ability to secrete proteins
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directly into the culture supernatant at gram-per-liter concen-
trations (13). The high secretion capacity, coupled with the
ease of fermentation and impressive safety record, has identi-
fied B. subtilis as an important host for efficient large-scale
secretion of a wide variety of heterologous proteins.
Secretion-competent preproteins are actively transported to
and across the cytoplasmic membrane by the translocase com-
plex, utilizing energy from ATP and the proton motive force
(40, 46). Following translocation, signal peptidases process the
preprotein, mediating the cleavage of the N-terminal signal
peptide and the release of the unfolded mature protein on the
trans side of the membrane. Many heterologous proteins are
subject to rapid degradation by host cell-associated proteases
before they are able to fold into their mature, usually more
proteolytically resistant, fully folded conformation (20, 27, 43).
Consequently, the speed and efficiency of in vivo folding of
secreted proteins directly affect their overall yield.
B. subtilis secretes seven extracellular proteases into the cul-
ture medium. Native secretory proteins which have coevolved
alongside these proteases are, for the most part, resistant to
their proteolytic activities. In contrast, heterologous proteins
are often highly susceptible to these proteases, prompting at-
tempts to engineer multiply-protease-deficient strains of B.
subtilis, such as WB600 (53). However, despite the fact that six
extracellular protease genes have been inactivated in this
strain, so that it exhibits just 0.32% of the proteolytic activity of
the wild type, the proteolytic degradation of heterologous pro-
teins has not been eliminated (28, 42). Even proteins that are
highly resistant to proteases in their fully folded state can be
rapidly and substantially degraded following translocation, sug-
gesting the existence of a degradation pathway associated with
the cell wall. This activity has been attributed, in part at least,
to the product of the wprA gene, which encodes a cell wall-
associated serine protease (26). Consequently, a B. subtilis
strain that was not able to express its wprA gene exhibited twice
the -amylase activity of the wild-type strain (43).
The identification of posttranslocational factors that partic-
ipate in protein folding may facilitate the optimization of het-
erologous protein secretion. Factors known to influence the
folding of secreted proteins include extracellular folding fac-
tors (e.g., PrsA) and the physicochemistry of the cell wall. PrsA
is an extracytoplasmic molecular chaperone located on the
trans side of the cytoplasmic membrane which functions as a
peptidyl-prolyl-cis-trans-isomerase (PPI). PrsA catalyzes the
conversion of proline residues from the cis configuration into
the trans configuration. This is the rate-limiting step for the
folding of many secretory proteins (50). Overproduction of
PrsA has been shown to increase the production of -amylase,
proteases, and single-chain antibody fragments (23, 50, 52).
The efficient folding of a number of secretory proteins is
dependent on the presence of divalent metal cations Fe3 or
Ca2 (10, 25, 34, 44). The importance of Ca2 to rPA stability
has been shown by growing B. subtilis in minimal medium with
and without CaCl2 (10 mg/liter); in the absence of Ca
2, little
if any rPA was detected by Western blotting (Leslie Baillie,
personal communication). The availability of metal cations to
act as folding effectors is determined by their concentration in
the environment and the properties of the anionic polymers
(teichoic and teichuronic acids) covalently attached to pepti-
doglycan in the cell wall.
Teichoic acids, including wall teichoic acids (WTA) and li-
poteichoic acids (LTA), are essential components of the cation
exchange system between the cell envelope and the surround-
ing environment. They confer a high density of negative charge
on the cell wall and the capacity to attract metal cations such
as Ca2, Fe3, and Mg2 (7, 17, 34). The ion exchange activ-
ities of teichoic acids are mediated by the presence of ester-
linked D-alanyl residues that control the overall negative
charge of the cell wall (16). The free amino moiety of each
D-alanyl residue is protonated at physiological pH, effectively
neutralizing the negative charge of a neighboring phosphate
residue on the teichoic acid molecule. Significantly, when ex-
tracellular cation concentrations are high, the effects of D-
alanylation are marginal, whereas at low cation concentrations
cell wall binding is significantly increased in the absence of
alanylation (24).
The D-alanylation of LTA and WTA in B. subtilis is deter-
mined by the products of the dlt operon. This operon is com-
posed of five genes, dltA to dltE. Insertional inactivation of
genes dltA to dltD results in the complete inhibition of D-
alanylation (32) but does not affect cell growth or metabolism.
However, these mutants are marginally more vulnerable to cell
lysis (51). Recent work has shown that inactivation of dltB or
dltD markedly increases the stability of certain secretory pro-
teins, especially those prone to proteolysis (18).
As a model secretory protein, B. anthracis protective antigen
has advantages over other model proteins, such as -amylases,
in that it is subject to proteolysis at both cell-associated and
extracellular locations. In this paper, we show that the degree
of cell wall alanylation influences the secretion of rPA by B.
subtilis. In particular, we show the kinetics of rPA secretion
and the relative contributions of proteolytic events that occur
before and after this protein is released from the cell. The
analysis and optimization of rPA secretion are likely to provide
insights into the key features of the B. subtilis secretion path-
way, which could be adapted to improve the yield of secreted
heterologous proteins.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains and plasmids are
listed in Table 1. All strains were maintained on antibiotic medium 3 plates
(Difco Laboratories Ltd., East Molesley, United Kingdom) or in liquid culture in
2xYT broth (1.6% tryptone, 1% yeast extract, 0.5% NaCl) buffered with 0.2 M
MES (morpholineethanesulfonic acid, pH 6.0). Pulse-chase labeling experiments
were carried out in Spizizen’s minimal salts medium (SMS) (41). For plasmid
maintenance, growth medium contained ampicillin (100 g/ml), erythromycin (1
g/ml), kanamycin (5 g/ml), and lincomycin (25 g/ml), as necessary.
Stability of rPA and AmyL in spent culture medium. Cultures of B. subtilis 168
and B. subtilis WB600 were grown for 24 h in 20 ml of 2xYT to allow the full
expression of extracellular proteases. The cells were removed by centrifugation
(10,000  g, 30 min, 4°C), and the spent medium containing extracellular pro-
teases was filtered through 0.45-m-pore Acrodisc-32 filters (Pall Gelman Sci-
ences, Ann Arbor, Mich.). Aliquots (5 l of 1 mg/ml) of purified rPA (31) and
AmyL (42) were added to 300 l of culture supernatant and incubated at 37°C.
Samples (20 l) were removed at intervals over a 36-h period to determine rPA
and AmyL levels by Western blotting.
DNA manipulations and PCR. Plasmid DNA extraction, restriction endonu-
clease digestion, ligation, agarose gel electrophoresis, and transformation of
electrocompetent E. coli cells were carried out as described previously (36).
Enzymes, molecular size markers, and deoxynucleotides were purchased from
Roche Diagnostics Ltd. (Lewes, United Kingdom) or Amersham Pharmacia
Biotech Ltd. (Little Chalfont, United Kingdom). Extraction of B. subtilis DNA
and transformation of B. subtilis by the Groningen method were done according
to Bron (9). The PCR was carried out as described previously (37) with Pfu
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(Stratagene Europe, Amsterdam, The Netherlands) or Taq DNA polymerase
(Promega UK Ltd., Southampton, United Kingdom), using the following cycling
program: 1 cycle of 5 min at 94°C and then 35 cycles of 1 min at 94°C, 1 min at
60°C, and 1 to 4 min at 72°C, depending on the size of the PCR product (36).
Plasmid pJET1 was created by amplification of the 5 end of the dltA gene by
PCR, using primers DLT-F (5-CGCGGATCCGGAGAGAGAATAACTATG
AAAC-3) and DLT-R (5-CGCGGATCCTTCGTTTTCCAGCAGTTCTTCC-
3). These primers were designed to include BamHI restriction sites (shown in
bold) to facilitate cloning. The recombinant plasmids were transformed into
competent B. subtilis cells, and transformants were selected on antibiotic medium
3 plates containing erythromycin and lincomycin. The mutants were analyzed by
PCR to confirm the integration of a single copy of the plasmid into the target
gene on the chromosome, using a strategy similar to that described previously
(37).
SDS-PAGE and Western blotting. Cultures were grown in 20 ml of 2xYT broth
buffered with 0.2 M MES (pH 6.0) at 37°C. Samples of culture supernatant (20
l), taken hourly throughout growth, were mixed with 20 l of 2 sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer
and then boiled for 5 min. The samples were run on a 10% polyacrylamide gel
alongside prestained low-range molecular size markers (Bio-Rad, Hercules, Cal-
if.). Proteins were transferred from the gel onto a 0.4-m nitrocellulose mem-
brane (Anderman Ltd., Kingston upon Thames, United Kingdom). rPA protein
was detected using rabbit polyclonal anti-PA antiserum followed by anti-rabbit
immunoglobulin-horseradish peroxidase conjugate (Dako Immunochemicals
A/S, Glostrup, Denmark). Protein bands were visualized by immersion in freshly
prepared Western blot staining solution containing 4-chloro-1-naphthol and hy-
drogen peroxide.
Analysis of D-alanine esters of wall teichoic acids. Cultures were grown in 20
ml of 2xYT broth buffered with 0.2 M MES (pH 6.0) at 37°C. Culture samples (1
ml) were removed at hourly intervals and centrifuged, and the resulting pellet
was stored at20°C. Cell disruption, alkaline hydrolysis of D-alanine from WTA,
and colorimetric assays to determine liberated D-alanine concentrations were
performed as described previously (18).
Pulse-chase experiments. Bacterial cultures were grown to exponential phase
in SMS, indicated by an optical density at 660 nm of 1.0. The culture was
pulse-labeled with L-[35S]methionine (561 kBq/l; Amersham International
Plc.), as described previously (43, 49). Following the chase, pairs of samples (750
l) were taken at various times (0, 2, 5, 7, 10, 15, 30, 45, and 60 min). The first
sample, containing cells and growth medium, represented total protein, while the
second sample, obtained by filtration through a 0.45-m-pore polyvinylidene
difluoride filter (Whatman, Maidstone, United Kingdom), represented protein
secreted into the culture medium. rPA in the samples was immunoprecipitated
with rPA-specific antibodies, and the immune complexes were recovered by
centrifugation. These were subjected to SDS-PAGE and analyzed by fluorogra-
phy. The relative amounts of radiolabeled rPA at each time point were deter-
mined by phosphoimaging (PhosphorImager; Molecular Dynamics) and ana-
lyzed using ImageQuant software (version 3.22; Molecular Dynamics).
-Galactosidase activity. Cultures were grown in 20 ml of 2xYT broth at 37°C.
Samples were removed to determine optical density at 660 nm and -galactosi-
dase activity as described previously (30).
Surface charge topology mapping. A three-dimensional model of the surface
topology of rPA was determined using the published crystallographic protein
structure data of anthrax protective antigen (35) (Swiss-Prot accession number
P13423). Loop regions for which the structure could not be determined were
omitted, as well as the two bound Ca2 ions. A three-dimensional solvent-
accessible contour map of rPA was created using the Sybyl 6.7 program (Tripos
Ltd., St. Louis, Mo.) using the Connolly surface method (11). The spatial distri-
bution of electrostatic potential was determined using the Poisson-Boltzmann
equation.
RESULTS
Stability of rPA in spent culture medium. The onset of
stationary phase triggers the synthesis by B. subtilis of a number
of extracellular proteases (33). We therefore determined the
effects of extracellular proteases released into the culture me-
dium on the stability of rPA. Stability was determined in spent
culture medium used for the growth of the wild-type B. subtilis
168 and derivative WB600, which is deficient in six extracellu-
lar proteases (53). A protease-resistant heterologous protein,
FIG. 1. Stability of rPA (open symbols) and AmyL (closed sym-
bols) in spent culture medium from B. subtilis 168 (squares) and
WB600 (circles). The proteins were detected by Western blotting and
are expressed as a percentage of the initial protein concentration.
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Description Comments Reference or source
Strains
B. subtilis 168 trpC2 Wild-type B. subtilis 1
B. subtilis DN1885 amyE amyR2 -Amylase-negative derivative of B.
subtilis 168
Novo Nordisk A/S
B. subtilis WB600 trpC2 nprE aprE epr bpf mpr nprB B. subtilis with six extracellular protease
genes knocked out
53
B. subtilis JET1 amyE, pPA101, Kmr DN1885 with rPA plasmid pPA101 This study
B. subtilis JET2 amyE, pPA101, IPTG-inducible dltA-E; Kmr
Emr Lmr
DN1885 JET1 with pMUTin4dltAFP
integrated at dltA
This study
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1
lac [F-proAB lacIqZ M15Tn10 (Tctr)]
Stratagene
Plasmids
pPA101 rPA; Kmr Derivative of pUB110 containing
recomibinant pagA
20
pMUTin4 Ampr Emr Lmr spoVG-lacZ Pspac 48
pMUTin4dltAFP Kmr Ampr Emr Lmr Integrated into the B. subtilis
chromosome at dltA
This study
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Bacillus licheniformis -amylase (AmyL), was included for
comparison (43).
In the presence of spent culture medium from the wild type,
rPA had a half-life of approximately 50 min (Fig. 1). In spent
medium from the protease-deficient strain WB600, the half-
life was extended to 12 h. The rapid proteolysis in the B. subtilis
168 supernatant is typical of a wide variety of heterologous
proteins secreted by B. subtilis. AmyL, however, was markedly
more stable; in the presence of wild-type levels of proteases,
80% of the initial protein was still present after 35 h, and this
was increased to 90% in spent medium from the protease-
deficient strain.
Construction of a mutant with an inducible dlt operon. To
determine the effects of D-alanylation on the secretion and
stability of rPA, we constructed a strain of B. subtilis in which
the entire dlt operon was placed under the control of an iso-
propylthio--D-galactopyranoside (IPTG)-inducible Pspac pro-
moter (Fig. 2). A 419-bp fragment from the 5 end of the dltA
gene was amplified from B. subtilis 168 chromosomal DNA
using oligonucleotide primers DLT-F and DLT-R. The prod-
uct was digested with BamHI, cloned in the pMUTin4 integra-
tional vector (48), and used to transform E. coli XL1-Blue
(Stratagene, La Jolla, Calif.). Diagnostic PCR, using vector-
and insert-specific primers, was used to screen for the presence
and correct orientation of the insert in the recombinant plas-
mids, and their structure was confirmed by sequencing the
entire insert and vector sequences on either side of the cloning
site (data not shown).
The resulting plasmid, pMUTin4dltAFP, was used to trans-
form B. subtilis JET1 to generate B. subtilis JET2
dltA::pMUTin4. The recombinant strain was tested by PCR to
verify the integrity of the construct. In this strain the expression
of the dlt operon was under the control of the Pspac promoter,
allowing the expression of the operon to be induced by the
addition of IPTG to the growth medium (48).
Influence of the dlt operon on WTA D-alanylation and rPA
secretion. B. subtilis 168 and JET2 dltA::pMUTin4 were grown
at 37°C in 2xYT, the latter with or without IPTG, until the
onset of stationary phase. Samples were taken to monitor
growth, the extent of WTA D-alanylation, and the yield of
secreted rPA. All of the strains exhibited similar growth kinet-
ics (Fig. 3A), confirming that the dlt operon has no obvious
effects on cell growth (32).
The D-alanylation of WTA was measured to determine the
activity of the dlt operon (Fig. 3B). In wild-type B. subtilis, the
extent of D-alanylation increased during transition to station-
ary phase and then decreased during stationary phase. If the
pH of the culture medium is increased to 8.1, the ester bond
linking the D-alanyl residue to teichoic acid becomes labile (22)
and as a result, no D-alanylated WTA could be detected (data
not shown). Analysis of the non-IPTG-induced JET2
dltA::pMUTin4 showed, as expected, an absence of D-alanine
FIG. 2. Construction of an IPTG-inducible dlt operon in B. subtilis DN1885 by cloning a 5 fragment of the dltA gene into the B. subtilis
integration vector, pMUTin4. The open flag represents the native dlt promoter, Pdlt, while the IPTG-inducible Pspac promoter is depicted by a solid
flag.
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residues in WTA. In contrast, alanylation was partially re-
stored when 1 mM IPTG was added to the culture medium.
However, the level of alanylation in the induced mutant (	1
mg of alanine/unit of culture OD) was only about one fifth of
that observed in the wild type. Increasing the concentration of
IPTG to 10 mM did not restore the level of alanylation to that
of the wild type (data not shown). The failure to restore the
level of alanylation in the JET2 dltA::pMUTin4 to that of the
wild type probably reflects the fact that the operator in this
construct has been optimized to achieve maximum repression
under noninducing conditions, with consequential limitations
to the extent to which the Pspac promoter can be induced (48).
The secretion of rPA was determined by Western blotting
(Fig. 3C). Wild-type B. subtilis secreted rPA to a maximum
concentration of 2 mg/liter, while that of the noninduced B.
subtilis JET2 dltA::pMUTin4 was 4.75 mg/liter. Induction of
the dlt operon in the mutant with 1 mM IPTG resulted in the
synthesis of an intermediate concentration of rPA (3 mg/liter),
which was compatible with the degree of alanylation observed
in this strain.
Transcriptional activity of the dlt operon. The activity of the
native dlt promoter was analyzed in B. subtilis JET2
dltA::pMUTin4, in which the native promoter was transcrip-
tionally fused to a lacZ reporter gene, enabling the transcrip-
tional activity to be monitored via -galactosidase activity (Fig.
4). Transcription of the dlt operon remained low during expo-
nential growth but, in agreement with previous reports (32),
was transiently induced during transition into stationary phase.
These data are consistent with the observed levels of WTA
alanylation (Fig. 3B). The transcription of the native dlt pro-
moter was independent of the presence of IPTG, indicating
that this operon is not autoregulated by products of the dlt
operon.
Pulse-chase analysis of rPA processing. The kinetics of rPA
secretion were determined by coupled pulse-chase/immuno-
precipitation experiments. Wild-type B. subtilis and JET2
dltA::pMUTin4, with and without 1 mM IPTG, were grown in
Spizizen’s minimal medium to exponential phase (OD660 of
approximately 1) and pulse-chased with L-[35S]methionine. Ra-
dioactively labeled rPA was immunoprecipitated, separated by
SDS-PAGE, and visualized by autoradiography (Fig. 5A). The
precursor form of rPA (mature protein plus signal peptide),
with a molecular mass of 85.8 kDa, was clearly distinguishable
from that of the mature form (82.7 kDa).
In the wild type, the processing of rPA from precursor to
mature form (Fig 5A) was relatively slow compared to other
secreted Bacillus proteins (e.g., AmyL) (43). Following the
addition of the nonradioactive chase (T0), only 50% of the
radioactively labeled rPA was in the mature form. The maxi-
mal amount of labeled mature rPA was recorded approxi-
mately 5 min following the chase, with the labeled precursor
form disappearing after approximately 10 min. The amount of
mature rPA decreased rapidly; at 30 min postchase, half had
been degraded, and virtually no mature rPA was detected after
60 min (Fig. 5A). The secreted mature rPA, representing 20%
of the maximum synthesized during the pulse, reached a peak
at 7 min and was completely degraded after approximately 40
min. These data confirm that rPA is subject to extensive deg-
radation during or shortly after translocation through the cy-
FIG. 4. -Galactosidase assay for transcriptional activity of the dlt
operon using a dltA::lacZ transcriptional fusion. Growth (solid sym-
bols) and -galactosidase activity (open symbols) were measured in
cultures of B. subtilis 168 (squares) and B. subtilis JET2 dltA::pMUTin4
with (diamonds) and without (circles) 1 mM IPTG.
FIG. 3. Phenotypic effects of dlt operon modulation using B. subtilis 168 (f) and B. subtilis JET2 dltA::pMUTin4 with (F) and without () 1
mM IPTG. (A) Growth kinetics in 2xYT–0.2 M MES (pH 6.5) determined at OD660. (B) D-Alanyl ester content of isolated wall teichoic acids,
detected by a colorimetric reaction. (C) Extracellular secretion of mature rPA into the culture medium, detected via Western blotting.
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toplasmic membrane and after secretion into the growth me-
dium.
Processing of precursor rPA in B. subtilis JET2
dltA::pMUTin4 (Fig. 5B and 5C) appeared to be slower than
that of the wild type, and significant amounts of the precursor
form were detected 15 min after the pulse. In the absence of
induction (i.e., no alanylation), the maximal level of labeled
mature rPA was detected approximately 15 min after the chase
and remained relatively stable for the next 30 min. Even at 60
min postchase, significant amounts of rPA were detectable
(Fig. 5B), both in whole culture samples and secreted into the
culture medium.
Induction of the dlt operon in B. subtilis JET2
dltA::pMUTin4 (Fig 5C) reduced the stability of rPA to a level
that was intermediate between that of the wild-type and the
noninduced mutant strain (Fig 5B). Processing of the precur-
sor protein into mature protein occurred at an intermediate
rate. Mature rPA peaked after 7 min at 50% of the total
synthesized during the pulse (cf. B. subtilis 168, 15%, and B.
subtilis JET2 dltA::pMUTin4 without IPTG, 60%). Similarly,
the secretion of rPA into the culture medium peaked at 30% of
the maximum at 7 min, and it was degraded relatively slowly
thereafter. In both the wild type and the mutant, there was a
consistent difference between the amount of mature rPA de-
tected in the whole culture and that secreted into the culture
medium. This difference is likely to be accounted for by rPA
trapped in the matrix of the cell wall.
Characterization of the surface topology of rPA. Protective
antigen from B. anthracis has a calculated pI of 5.58. In order
to determine the distribution of electrostatic potential on the
surface of rPA, a three-dimensional solvent-accessible model
was generated. The model shows clear variations in charge
distribution; the surface is predominantly negatively charged,
but with the strongly positively and negatively charged regions
projecting from the main body of the protein. An exception is
a concentration of negatively charged residues in domain 1
(35) and a strongly electropositive region corresponding to the
convergence of three lysine residues.
The distribution of surface charge is likely to influence the
interaction of rPA with the negatively charged cell wall of B.
subtilis during secretion. The negatively charged face of rPA is
likely to be repelled by the cell wall, whereas the positively
charged projections may facilitate cell wall binding (44). The
latter may be responsible for the discrepancy between the
amount of rPA synthesized and that released into the culture
medium (Fig. 5).
DISCUSSION
Obtaining high yields of secreted rPA from B. subtilis has
been hampered by marked proteolytic degradation (5). At-
tempts to eliminate this degradation using B. subtilis WB600, a
protease-deficient strain in which six out of seven extracellular
protease genes have been inactivated (4, 53), have only been
partially successful. Here we report a 15-fold increase in the
half-life (from 0.8 to 12 h) of rPA in spent culture medium
from a protease-deficient strain compared with the wild type.
This was in marked contrast to B. licheniformis -amylase,
FIG. 5. Secretion of rPA from exponentially growing cultures of B. subtilis in the presence and absence of the products of the dlt operon.
Representative data are shown for pulse-chase experiments carried out on strains B. subtilis 168 and B. subtilis JET2 dltA::pMUTin4 with and
without 1 mM IPTG. (A) Autoradiographs of pulse-chased rPA following immunoprecipitation with anti-rPA polyclonal antibodies and SDS-
PAGE. The top gels in panel A indicate precursor (p) and mature (m) rPA immunoprecipitated from whole-culture samples, and the bottom gels
indicate mature rPA released into the culture medium. (B) Quantification by phosphoimaging of the different forms of rPA at different times
following the chase. f, rPA precursor; , mature rPA in whole-culture samples; F, mature rPA released into the growth medium. The amount
of each form of rPA is expressed as a percentage of the total rPA (precursor plus mature) synthesized during the pulse.
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which was stable over extended periods, even in spent culture
medium derived from the wild type. rPA therefore represents
a useful model for proteins that are subject to rapid proteolysis
by B. subtilis extracellular proteases.
The recent observation that incompletely folded secretory
proteins are more susceptible to proteolysis that their natively
folded counterparts has focused attention on the identification
of cotranslocational and posttranslocational events that influ-
ence the secretion of proteins from B. subtilis (8, 18, 43).
Proteins may be most susceptible to proteolysis as they emerge
from the translocase, and factors that increase the rate at
which they achieve their native state are likely to promote
protein stability and hence increase the overall recoverable
yields. Thus, characterization of this environment and factors
involved in efficient protein folding may provide insights for
the optimization of heterologous proteins.
The microenvironment on the trans side of the cytoplasmic
membrane into which proteins are secreted is controlled and
maintained by the physicochemical properties of the mem-
brane and the cell wall. The net charge in this region is mod-
ulated by the extent of D-alanylation of wall and lipoteichoic
acids, which in turn affect the concentration of metal cations
such as Ca2, Fe2, and Mg2 at the cell membrane/wall
microenvironment (7, 17, 18). These cations are required as
folding factors for a variety of secreted proteins, including
-amylase and levansucrase (10, 25, 34, 44). The presence of
calcium ions in the native structure of anthrax protective an-
tigen means that metal ions are also likely to be important for
the folding of this protein (35). In the absence of D-alanylation,
the negative charge density in the wall increases, as does its
affinity for metal cations (24). This in turn increases the avail-
ability of these cations to act as folding effectors and hence
increases the rate of protein folding (18).
In contrast to previous studies in which the dltB and dltD
genes have been insertionally inactivated (18), we have con-
structed a mutant in which the expression of the dlt operon has
been placed under the control of the IPTG-inducible Pspac
promoter (48). In comparison to the wild type, the yield of
secreted rPA, as detected by Western blotting, was significantly
increased in the noninduced mutant.
Analysis of rPA secretion kinetics by pulse-chase showed
that rPA was stabilized in the absence of D-alanylation, leading
to the release of increased amounts of mature rPA secreted
into the culture medium. However, there was a consistent
difference between the total amount of rPA synthesized during
the pulse and the amounts released into the culture medium.
This difference probably represents cell-associated degrada-
tion by wall- and/or membrane-associated proteases occurring
shortly after translocation of the protein across the cytoplasmic
membrane. In addition, the rate of precursor processing and
cell-associated degradation is higher in the wild type than in
the nonalanylated mutant.
The pulse-chase experiments also highlight a discrepancy, of
approximately 10%, between the amount of mature rPA in the
whole culture and that secreted into the culture medium. This
may represent an interaction between a portion of the rPA
protein and the cell wall. Physical-chemical interactions be-
tween the cell wall and secreted proteins have been suggested
to inhibit the release of certain heterologous proteins (38).
Although there is no definitive in vivo evidence for such inter-
actions, except for native wall-associated proteins (2), studies
using chimeric -amylases with modified net charge have
shown that positively charged proteins may be retarded by
electrostatic interactions with the cell wall (21, 44). Analysis of
the surface charge topology of rPA indicated that one face was
negatively charged, while the opposing face had a number of
positively charged projections that may facilitate interactions
with the cell wall.
The use of B. subtilis as a host provides many advantages
over the currently licensed method for the production of an-
thrax protective antigen. However, rPA, like many other het-
erologous proteins, is subjected to proteolytic attack by host
cell proteases. The use of rPA as a model protein for investi-
gating cell-associated and extracellular factors affecting protein
stability is likely to prove valuable, not only for the production
of the next generation of anthrax vaccines, but also for the
secretion of other heterologous proteins of commercial and
medical importance from B. subtilis.
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